- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER-2 Positive Breast Cancer in United Kingdom
Total 6042 results
-
University of LeedsBreast Cancer NowCompletedMetastatic Breast CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
University of AberdeenNHS GrampianUnknownMalignant Breast Tissue NeoplasmUnited Kingdom
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
Royal Marsden NHS Foundation TrustRecruitingBreast Cancer | LymphedemaUnited Kingdom
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast CarcinomaUnited States
-
Manchester University NHS Foundation TrustCompletedBreast CancerUnited Kingdom
-
University of OxfordBlue Earth DiagnosticsCompleted
-
NHS TaysideUniversity of DundeeCompleted
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
NHS Greater Glasgow and ClydeCanniesburn Research TrustUnknownBreast CancerUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
St George's, University of LondonUnknownBreast Cancer | Fatigue | Cancer Survivor | Psychosocial Effects of Cancer and Its TreatmentUnited Kingdom
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Thomas Jefferson UniversityActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 and other conditionsUnited States
-
Yale UniversityAstraZenecaNot yet recruitingBreast Cancer | Hyperinsulinism | HER2-negative Breast CancerUnited States
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
King's College Hospital NHS TrustRecruitingBreast CancerUnited Kingdom
-
Lightpoint Medical LimitedNot yet recruiting
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompleted
-
Imperial College LondonTerminatedBreast CancerUnited Kingdom
-
University of StirlingOxford Brookes University; University of BathWithdrawn
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom
-
AstraZenecaCompleted
-
Institute of Cancer Research, United KingdomGlaxoSmithKlineCompletedBreast CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknown
-
Imperial College LondonMedical Research Council; University of CambridgeRecruiting
-
Royal Marsden NHS Foundation TrustImperial College Healthcare NHS TrustCompleted
-
Royal Marsden NHS Foundation TrustInnovate UKActive, not recruitingBreast CancerUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustInnovate UK; PinPoint Data Science Ltd.Suspended
-
University of NottinghamInnovate UKWithdrawn
-
Lightpoint Medical LimitedKing's College London; Guy's and St Thomas' NHS Foundation TrustCompleted
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Genentech, Inc.Approved for marketing
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
NHS Greater Glasgow and ClydeUnknownBreast Cancer | Nail ToxicityUnited Kingdom
-
University of LeedsThe Leeds Teaching Hospitals NHS Trust; European Organisation for Research...Completed
-
Closed Loop MedicineCompleted
-
TTC Oncology, LLCCompletedMetastatic ER+ Breast CancerUnited States
-
Lunit Inc.King's College London; The Leeds Teaching Hospitals NHS TrustNot yet recruitingBreast Cancer | Breast DiseasesUnited Kingdom
-
PerspectumRecruitingBreast Cancer | Breast DiseasesUnited Kingdom
-
CCTU- Cancer ThemeBreast Cancer Now; CRUK Cambridge InstituteRecruiting
-
NHS TaysideCompleted